Adrianne Lee - 23 Jan 2026 Form 4 Insider Report for BED BATH & BEYOND, INC. (BBBY)

Signature
/s/ Christina Wheeler, Attorney-in-Fact
Issuer symbol
BBBY
Transactions as of
23 Jan 2026
Net transactions value
-$41,555
Form type
4
Filing time
27 Jan 2026, 16:06:16 UTC
Previous filing
22 Jul 2025
Next filing
06 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Adrianne President & CFO 433 ASCENSION WAY, 3RD FLOOR, MURRAY /s/ Christina Wheeler, Attorney-in-Fact 27 Jan 2026 0001807266

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBBY Common Stock Options Exercise $2.1 +20,965 +35% $0.000100 81,399 23 Jan 2026 Direct
transaction BBBY Common Stock Tax liability $41,557 -6,049 -7.4% $6.87 75,350 23 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBBY Restricted Stock Units Options Exercise $0 -20,965 -22% $0.000000 75,336 23 Jan 2026 Common Stock 20,965 Direct F1
transaction BBBY Common Stock Warrant Award $0 +6,043 $0.000000 6,043 07 Oct 2025 Common Stock 6,043 $15.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units have vested in three equal installments at the close of business on January 23, 2024, January 23, 2025, and January 23, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules.
F2 Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one common share at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.